Table 5.
Logistic Regression Analysis for Tuberculosis Infection in Women With Human Immunodeficiency Virus
| Regimen and Viral Load | AOR | (95% CI) | P Value |
|---|---|---|---|
| ART regimen | |||
| ZDV + 3TC + NVP | Ref | … | |
| ZDV + 3TC + EFV | 0.261 | (.027–2.50) | .24 |
| TDF + 3TC + EFV | 0.288 | (.086–.971) | .045 |
| TDF + 3TC + NVP | 0.125 | (.024–.640) | .013 |
| Viral load, copies/mL | |||
| < 1000 | Ref | … | |
| ≥ 1000 | 0.275 | (.098–.773) | .014 |
Multivariate logistic regression for tuberculosis infection (TB+) in women with human immunodeficiency virus using the conventional cutoff (0.35 IU/mL) for QuantiFERON-TB Gold-Plus. The model was constructed in a stepwise forward selection method, with variables with univariate P < .10 eligible for inclusion and likelihood ratio test used to determine the contributed model fitness. Bonferroni-adjusted level of significance: 0.0031.
Abbreviations: 3TC, lamivudine; AOR, adjusted odds ratio; ART, antiretroviral therapy; CI, confidence interval; EFV, efavirenz; NVP, nevirapine; TDF, tenofovir disoproxil fumarate; ZDV, zidovudine.